Posts by Dr. Khanh Nguyen
David Sinclair’s ER-100 Clinical Trial: First Human Data on Glaucoma and Epigenetic Reprogramming
Protecting your vision means protecting the freedom to read, drive, travel, and enjoy the people and activities you love. That is why a new clinical trial in glaucoma is drawing attention far beyond eye care. On June 9, 2026, Life Biosciences, co-founded by Harvard Medical School geneticist Dr. David Sinclair, announced that the first participant…
Read MoreFrom Biohacking to Precision Longevity: Why the Modern Longevity Clinic Is Changing the Future of Healthy Aging
Most people don’t think about aging until they notice something has changed. Energy levels begin to decline. Recovery after exercise takes longer. Sleep becomes less restorative. Body composition shifts despite maintaining the same habits. Lab results that once looked perfect start trending in the wrong direction. The challenge is that many of these changes occur…
Read MoreFrom Biological Age to Healthspan: How Clinics Are Tracking Aging More Precisely
Most people think about aging in birthdays and decades. But inside the body, aging is far more dynamic. Two people can be the same chronological age and have completely different levels of cardiovascular health, metabolic function, cognitive performance, recovery capacity, and inflammation. That is where biological age testing is changing the conversation around longevity. At…
Read MoreYoung Plasma Exchange for Inflammation: Why Longevity Medicine Is Paying Attention
One of the biggest shifts happening in longevity medicine right now is the realization that aging is not only about damaged tissues or worn-down joints. It is also about the biochemical messages circulating through the body every second of the day. Your blood is constantly carrying signals that influence inflammation, immune activity, recovery, energy production,…
Read MoreSafety of Plasma from Vaccinated Donors: What Longevity Patients Need to Know
Quick answer: Is plasma from vaccinated donors safe? Safety of plasma from vaccinated donors is supported by current evidence from large hospital studies and transfusion-medicine experts, which show no increase in blood clots, respiratory complications, or death among recipients. A 2025 analysis highlighted by AABB and America’s Blood Centers found no additional risk tied to donor vaccination status. Vaccine mRNA…
Read More